[IPp] Chromium's effect on childhood diabetes to be studied
- To: Rachel A <email @ redacted>
- Subject: [IPp] Chromium's effect on childhood diabetes to be studied
- From: Rachel A <email @ redacted>
- Date: Fri, 18 Feb 2005 19:45:41 -0800 (PST)
- Comment: DomainKeys? See http://antispam.yahoo.com/domainkeys
- Reply-To: email @ redacted
Chromium's effect on childhood diabetes to be studied
Product News related to :-->
17/02/2005 - The first clinical trial into the effects of chromium
supplementation in children with type 1 diabetes is now underway at the
Childrens Hospital in Los Angeles, announced Nutrition 21, which is supplying
Chromax chromium picolinate for the study.
There is strong scientific evidence to suggest that supplemental chromium
picolinate may improve insulin sensitivity, blood glucose control, and
cardiovascular risk factors in adults with type 2 diabetes, said Dr Francine
Kaufman, director of the hospitals Comprehensive Childhood Diabetes Center and
former president of the American Diabetes Association (ADA), who is leading the
It is of great interest to us to see if chromium picolinate will help young
people better manage their diabetes to maximize their long-term health and
quality of life.
The study sets out to see whether the addition of 600 mcg of chromium to the
daily diet of patients with poorly controlled type 1 diabetes aged between 12-
to 18-years will improve blood glucose and body weight.
The 30 participants (male and female) have all had type 1 diabetes for one year
or more, have had a glycosolated hemoglobin (HbA1c) of 7 percent or greater
within the last three months and a body mass index (BMI) in the top 15 percent
of their age and gender group.
The researchers will monitor the patients HbA1c levels as a measure of
long-term glycemic control, as well as glucose levels, body weight, BMI, lipid
profiles, enzymes and blood pressure.
James Komorowski, vice president of technical services and scientific affairs
at Nutrition 21, said: This study is important because of the growing need for
a safe and effective method of treating insulin resistance in children with and
at risk for diabetes.
Nutrition 21 cites upwards of 15 scientific studies that support the safety of
the trace mineral and its role in improving insulin function and glucose
metabolism in people with type 2 diabetes and related conditions.
Four other clinical trials using chromium picolinate are expected to be
initiated this year and funded by the National Institutes of Health, which
received an $800 million boost to its budget for further research into disease
thanks to the labor/health subcommittee bill that was signed into law by
President Bush in December 2002.
Its good to have academics from NIH involved as it takes the importance of
this program to another level and it helps to attract the attention of the
traditional medicine community, Gail Montgomery, president of Nutrition 21,
told NutraIngredients-USA.com in December.
Until now, general practitioners have paid too little attention to the
potential benefits of chromium, believes Montgomery, but the governments
current efforts to curb the rise of diabetes may change this.
According to the ADA, one in every 400 to 500 American children and adolescents
has type 1 diabetes, and about 210,000 people under the age of 20.
Rachel - email @ redacted/jracheln
Do you Yahoo!?
Yahoo! Mail - Find what you need with new enhanced search. Learn more.
for HELP or to subscribe/unsubscribe/change list versions,